Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Compressible Limb and Circulation Therapy System, Model POWER-Q2300

K-Number: K211283 · 2021-09-14

ApplicantWonjin Mulsan Co., Ltd.
Decision Date2021-09-14
Product CodeIRP
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Compressible Limb and Circulation Therapy System, Model POWER-Q2300 is a medical device manufactured by Wonjin Mulsan Co., Ltd.. It received FDA 510(k) clearance on 2021-09-14 under approval number K211283. The device is classified under product code IRP. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Compressible Limb and Circulation Therapy System, Model POWER-Q2300?

Compressible Limb and Circulation Therapy System, Model POWER-Q2300 is a medical device that received FDA 510(k) clearance on 2021-09-14. It is manufactured by Wonjin Mulsan Co., Ltd.. The 510(k) number is K211283.

When was Compressible Limb and Circulation Therapy System, Model POWER-Q2300 approved by the FDA?

Compressible Limb and Circulation Therapy System, Model POWER-Q2300 received FDA 510(k) clearance on 2021-09-14, under approval number K211283.

What company makes Compressible Limb and Circulation Therapy System, Model POWER-Q2300?

Compressible Limb and Circulation Therapy System, Model POWER-Q2300 is manufactured by Wonjin Mulsan Co., Ltd..

What is the FDA product code for Compressible Limb and Circulation Therapy System, Model POWER-Q2300?

The FDA product code for Compressible Limb and Circulation Therapy System, Model POWER-Q2300 is IRP.

Related Clinical Trials

NCT01143558 Searching for Persistence of Infection in Lyme Disease COMPLETED NCT06011187 Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery COMPLETED NCT05016219 Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients RECRUITING NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING NCT07613476 Pregabalin Phonophoresis for Carpal Tunnel Syndrome Pain ACTIVE_NOT_RECRUITING

Related PubMed Literature

PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 40942702 Digital Cardiovascular Twins, AI Agents, and Sensor Data: A Narrative Review from System Architecture to Proactive Heart Health. Sensors (Basel, Switzerland) (2025) PMID: 40624966 Peptide-Enhanced Bioactive Hydrogel Combined with Photodynamic-Phage Synergistic Antibacterial Therapy System Accelerates Infected Wound Healing. Advanced healthcare materials (2025) PMID: 39925011 Is more data always better? On alternative policies to mitigate bias in Artificial Intelligence health systems. Bioethics (2025)

Other Devices by Wonjin Mulsan Co., Ltd.

K200660Compressible Limb and Circulation Therapy System

Related Devices (Code: IRP)

K160608NormaTec Pulse and NormaTec Pulse ProNormaTec Industries, LP K171685Med4 EliteCool Systems, Inc. (Dba Game Ready) K161907Pressure Therapy SystemXiamen Senyang Co., Ltd. K163280RP Lite 760RMego Afek AC , Ltd. K160178Lympha-Flow(LF1200)Daesung Maref Co., Ltd. K183169Pulse 2.0, Pulse Pro 2.0NormaTec Industries, LP

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑